AzTrials
AzTrials

Central SensitizationNCT05937503

Efficiency of Manual Therapy on Central Sensitization in Patients With Nonspecific Chronic Back Pain

A study testing manual therapy and conventional physiotherapy in people with Central Sensitization and Manual Therapy, run by Atılım University at 2 sites in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Central sensitization (CS) is defined as the increased responsiveness of nociceptive neurons in the central nervous system to normal or subthreshold afferent input. CS has been proposed as an underlying mechanism of chronic pain in musculoskeletal disorders including low back pain (LBP). Read more about this study

Who is it for?
Ages 20 to 64 years
Conditions the study is for
Central Sensitization, Manual Therapy
What is being tested?
manual therapy and conventional physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesTurkey (Türkiye)
Study dates
17 Jul 2023to 30 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • non-spesific low back pain patients with pain longer than 12 weeks
  • aged between 20-64 years male and female participants

Who cannot join

  • concomitant disease that would interfere with treatment
  • pregnancy
  • have had any spinal surgery or fracture

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Naime Ulug

    Ankara, Select State, 06830

  • Atılım University

    Ankara

Other trials in Turkey (Türkiye)

About this study

Official title: Efficiency of Manual Therapy on Central Sensitization in Patients With Nonspecific Chronic Back Pain.A Randomized Controlled Study.

Central sensitization (CS) is defined as the increased responsiveness of nociceptive neurons in the central nervous system to normal or subthreshold afferent input. CS has been proposed as an underlying mechanism of chronic pain in musculoskeletal disorders including low back pain (LBP).

The aim of this study is to investigate the effect of manual therapy on central sensitization in patients with nonspecific chronic LBP.

Read the detailed description

A total of 40 LBP patients aged between 24-64 with CSS will be randomized into two groups. The manual therapy group will receive a 4-week manual therapy (two sessions/week) plus the conventional physiotherapy program, while the control group will only receive conventional physiotherapy. Before and after the interventions pain intensity (VAS), and scores of three questionnaires: Oswestry Disability Index (ODI), Central Sensitization Inventory (CSI), and the 36-item Short Form Health Survey Questionnaire (SF-36) will be recorded.The outcomes of the study will be analyzed by appropriate statistical methods.

Being tested
manual therapy, conventional physiotherapy
Keywords
central sensitization, manual therapy, non-specific low back pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • manual therapyOther

    Also called conventional physiotherapy

    The manual therapy group will receive a 4-week manual therapy plus conventionel physiotherapy.

  • conventional physiotherapyOther

    Control group will only receive conventionel physiotherapy intervention.

Study groups in NCT05937503
Study groupRoleWhat they receive
Manual therapyExperimentalManual therapy group
Receives: Other: manual therapy; Other: conventional physiotherapy
Conventional physiotherapyOtherConventional physiotherapy group
Receives: Other: manual therapy; Other: conventional physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    A 10 cm Visual Analog Scale will be used to determine the severity of pain, with numbers ranging from "0" (no pain) to "10" (unbearable pain)

    Measured: Up to one month

  2. Central Sensitization

    Central Sensitization Inventory (CSI) scale will be used severity of central sensitization.The total score range of the scale, which consists of a total of 25 questions, is between 0-100 points. Central sensitization with a score of 40 and above is considered positive. An increase in the total score indicates an increase in the level of central sensitization.

    Measured: Up to one month

Secondary outcomes (3)
  1. Oswestry Disability Index

    Oswestry Disability Index (ODI) will be used to measure disability level

    Measured: Up to one month

  2. Health Survey

    36-item Short Form Health Survey Questionnaire (SF-36) will be used

    Measured: Up to one month

  3. Hospital Anxeity and depresssion

    Hospital Anxeity and Depression Scale will be used. The cut-off points for caseness of anxiety or depression is 8/21 for anxiety or depression. For anxiety (HADS-A) this gave a specificity of 0.78 and a sensitivity of 0.9. For depression (HADS-D) this gave a specificity of 0.79 and a sensitivity of 0.83.

    The scores of the scale are as follows: 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)

    Measured: Up to one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2023
  2. Study start17 Jul 2023 (estimated)
  3. Primary completion30 Aug 2023 (estimated)
  4. Study completion30 Aug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
prospective randomized controlled study
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05937503
Sponsor's protocol ID
E-59394181-604.01.02-33380
Status last verified
Jul 2023
First submitted
27 Jun 2023
Last updated
18 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing manual therapy and conventional physiotherapy in people with Central Sensitization and Manual Therapy, run by Atılım University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Up to one month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in